Defibrillators

(asked on 9th September 2015) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the effect of the removal of implantable cardiac defibrillators from the high cost drugs and devices list, as part of 2016-17 national tariff proposals.


Answered by
 Portrait
Ben Gummer
This question was answered on 17th September 2015

The Health and Social Care Act 2012 gives responsibility for National Tariff to Monitor and NHS England. The decision to propose removing implantable cardiac defibrillators from the high cost list was made given the available evidence on costs, including reference cost data and device costs collected from the National Health Service. Monitor and NHS England will be listening to feedback on the proposal and adding this evidence to that already collected before making a final proposal for the 2016/17 National Tariff in the Consultation.

The Office for Life Science and the Department are conducting the Innovative Medicines and Medical Technology Review, which will be led by Sir Hugh Taylor. The review will make recommendations to Government on reform to accelerate access for NHS patients to innovative medicines and medical technologies (including devices and diagnostics).

Reticulating Splines